Adrenocorticotropic Hormone versus Prednisolone for Infantile Epileptic Spasms Syndrome: A Systematic Review and Economic Evaluation
Neuropediatrics · 01.04.2025 · 56 (02) · 102-110
DOI: 10.1055/a-2517-7800 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Neuropediatrics, erschienen am 01.04.2025. Verfasst von Ruonan Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University; Children's Medicine Key Laboratory …. Hauptthemen laut MEDLINE: Spasms, Infantile, Prednisolone, Adrenocorticotropic Hormone, Anticonvulsants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation for Young Scholars of China, Sichuan Natural Science Foundation Youth Fund Project.
Abstract (Originalsprache)
Background
Infantile epileptic spasms syndrome (IESS) is the most common epileptic encephalopathy in infancy and early childhood. At present, adrenocorticotropic hormone (ACTH) and prednisolone are commonly used as drug treatment regimens for IESS. However, evidence of efficacy and economics remains controversial. This study aimed to evaluate the effectiveness, safety, and economy of ACTH and prednisolone of IESS.
Methods
Seven literature databases and two clinical trial registration platforms were searched, and a meta-analysis was conducted. From the perspective of the health care system, a 14-day economic evaluation was conducted. The rate of spasm cessation on the 14th day was used as the effect index. The univariate sensitivity analysis was used to verify the robustness of the results.
Results
Nine randomized controlled trials (RCTs) were included. Current clinical evidence is not sufficient to prove the difference in the rate of spasm cessation on the 14th day (risk ratio [RR] = 1.05, 95% CI 0.86–1.27, p = 0.64) and total adverse event rate (RR = 0.87, 95% CI 0.53–1.42, p = 0.57). ACTH had an advantage in improving electroclinical response on the 14th day (RR = 1.46, 95% CI 1.09–1.96, p = 0.01) and reducing the number of months taken for relapse (mean difference = 1.65, 95% CI 1.01–2.29, p < 0.01). The cost of ACTH and prednisolone was 5,629.19 yuan and 5.56 yuan, respectively. Univariate sensitivity analysis showed the most influential factor was the cost of ACTH.
Conclusions
There is insufficient evidence to determine whether ACTH or prednisolone is better in the short-term regimen of IESS. ACTH may have more advantages in improving the long-term outcome of IESS. In China, a prednisolone regimen of IESS has a lower cost within 14 days.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University; Children's Medicine Key Laboratory of Sichuan Province, Chengdu, China.
- NMPA Key Laboratory for Technical Research on Drug Products In Vitro and In Vivo Correlation, Chengdu, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Chengdu, China.
- West China School of Medicine, Sichuan University, Chengdu, China.
- Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
- Laboratory of Molecular Translational Medicine, Center for Translational Medicine, Sichuan University, Chengdu, China.
ORCID-Profile: Ruonan Gao, Liang Huang
Förderung
- National Natural Science Foundation for Young Scholars of China
- Sichuan Natural Science Foundation Youth Fund Project
Zitieren
APA
Gao, R., Cheng, X., Huang, L., Luo, R., Zeng, L., Cheng, G., Yu, Q., Li, H., & Zhang, L. (2025). Adrenocorticotropic Hormone versus Prednisolone for Infantile Epileptic Spasms Syndrome: A Systematic Review and Economic Evaluation. Neuropediatrics, 56(02), 102-110. https://doi.org/10.1055/a-2517-7800
Vancouver
Gao R, Cheng X, Huang L, Luo R, Zeng L, Cheng G, et al. Adrenocorticotropic Hormone versus Prednisolone for Infantile Epileptic Spasms Syndrome: A Systematic Review and Economic Evaluation. Neuropediatrics. 2025;56(02):102-110. doi:10.1055/a-2517-7800
BibTeX
@article{Gao2025,
author = {Gao, Ruonan and Cheng, Xiao and Huang, Liang and Luo, Rong and Zeng, Linan and Cheng, Guo and Yu, Qin and Li, Hailong and Zhang, Lingli},
title = {Adrenocorticotropic Hormone versus Prednisolone for Infantile Epileptic Spasms Syndrome: A Systematic Review and Economic Evaluation},
journal = {Neuropediatrics},
year = {2025},
volume = {56},
number = {02},
pages = {102--110},
doi = {10.1055/a-2517-7800}
}
EUVIMED